We are live on ! Find out more
CCM

Compass Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 7.83%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+7.83%
3 Year Est. Return
+47.1%
5 Year Est. Return
+55.91%
10 Year Est. Return
+237.22%
AUM
$444M
AUM Growth
+$33.4M
Cap. Flow
+$8.14M
Cap. Flow %
1.83%
Top 10 Hldgs %
33.84%
Holding
59
New
8
Increased
29
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$860K
2
PFE icon
Pfizer
PFE
+$840K
3
SHW icon
Sherwin-Williams
SHW
+$785K
4
ACN icon
Accenture
ACN
+$701K
5
MSFT icon
Microsoft
MSFT
+$624K

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Industrials 17.02%
3 Technology 15.59%
4 Consumer Staples 9.84%
5 Materials 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
1
Ecolab
ECL
$78.5B
$16.1M 3.62%
162,719
-1,594
-1% -$148K
ITW icon
2
Illinois Tool Works
ITW
$82.5B
$15.6M 3.52%
204,942
-1,048
-0.5% -$76.6K
TMO icon
3
Thermo Fisher Scientific
TMO
$213B
$15.2M 3.43%
165,192
-67
-0% -$6.06K
JCI icon
4
Johnson Controls International
JCI
$88.8B
$14.9M 3.36%
343,372
-15,937
-4% -$675K
DHR icon
5
Danaher
DHR
$138B
$14.9M 3.35%
319,424
+210
+0.1% +$9.53K
FDX icon
6
FedEx
FDX
$73B
$14.9M 3.34%
130,241
+1,774
+1% +$191K
SHW icon
7
Sherwin-Williams
SHW
$82.6B
$14.8M 3.33%
243,738
+13,368
+6% +$785K
MDT icon
8
Medtronic
MDT
$110B
$14.8M 3.33%
277,587
-460
-0.2% -$24.8K
EXPD icon
9
Expeditors International
EXPD
$22B
$14.6M 3.29%
332,001
-6,020
-2% -$250K
DCI icon
10
Donaldson
DCI
$10.9B
$14.6M 3.27%
381,632
+13,406
+4% +$496K
NVS icon
11
Novartis
NVS
$297B
$14.4M 3.25%
210,028
+4,527
+2% +$300K
CVS icon
12
CVS Health
CVS
$134B
$14.4M 3.24%
253,336
+2,378
+0.9% +$142K
ADP icon
13
Automatic Data Processing
ADP
$106B
$14.4M 3.23%
226,060
+2,245
+1% +$143K
JNJ icon
14
Johnson & Johnson
JNJ
$622B
$14.2M 3.2%
164,143
+2,319
+1% +$208K
BEN icon
15
Franklin Resources
BEN
$17.5B
$14M 3.16%
277,458
+12,057
+5% +$582K
SIAL
16
DELISTED
SIGMA - ALDRICH CORP
SIAL
$14M 3.14%
163,681
+3,139
+2% +$264K
MSFT icon
17
Microsoft
MSFT
$3.43T
$13.9M 3.14%
418,929
+18,960
+5% +$624K
SYK icon
18
Stryker
SYK
$125B
$13.9M 3.13%
205,987
+4,673
+2% +$323K
ACN icon
19
Accenture
ACN
$102B
$13.7M 3.08%
186,115
+9,463
+5% +$701K
WMT icon
20
Walmart Inc
WMT
$888B
$13.3M 3%
540,639
+34,107
+7% +$860K
QCOM icon
21
Qualcomm
QCOM
$156B
$13.3M 2.99%
197,467
+5,228
+3% +$343K
ORCL icon
22
Oracle
ORCL
$371B
$13.1M 2.96%
395,996
+18,536
+5% +$601K
PG icon
23
Procter & Gamble
PG
$335B
$12.8M 2.87%
168,908
+5,873
+4% +$467K
SYY icon
24
Sysco
SYY
$41B
$12.4M 2.78%
388,434
+13,803
+4% +$463K
CAG icon
25
Conagra Brands
CAG
$7.02B
$2.75M 0.62%
116,588
-4,478
-4% -$121K

Similar funds

Compass Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Compass Capital Management held 59 positions worth $444M, up 8.1% from $411M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Compass Capital Management's Q3 2013 filing shows 8 new, 29 increased, 15 reduced and 4 closed positions. Its largest new stake was Pfizer: 30,856 shares worth $841K. The largest sale was Johnson Controls International, an estimated $675K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Technology.

  • Compass Capital Management's largest Q3 2013 buy was Pfizer: 30,856 shares worth $841K.
  • Compass Capital Management added most to Walmart Inc in Q3 2013, an estimated $860K increase.
  • Compass Capital Management's biggest Q3 2013 reduction was Johnson Controls International, cutting an estimated $675K.
  • Compass Capital Management fully exited Novo Nordisk in Q3 2013, selling an estimated $343K.
  • Compass Capital Management's ten largest holdings make up 34% of its $444M portfolio in Q3 2013.
  • Compass Capital Management opened 8 new positions and closed 4 in Q3 2013.
  • Compass Capital Management's portfolio value rose 8.1% quarter-over-quarter to $444M.

Based on Compass Capital Management's 13F filing for Q3 2013, filed 24 Oct 2013.